BBLG Q3 2024 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$951,021

Net Income

-$941,002

EPS (Diluted)

$-2.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$572,162

Free Cash Flow

-$572,162

Stock-Based Comp.

$17,941

Balance Sheet

Total Assets

$4M

Total Liabilities

$273,402

Stockholders' Equity

$4M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$951,021	-$2M	+54.3%
Net Income	-$941,002	-$2M	+51.0%